Tag: ERA
SanReno Therapeutics announces acquisition by Novartis, underscoring China’s substantial renal market...
SanReno Therapeutics has announced that it has been acquired by Novartis, becoming an indirect, wholly-owned subsidiary of Novartis. The investors that helped found SanReno—including...
PVI 2021: Global standardisation of guidelines and patient-first approach to kidney...
In the future, a global approach to help standardise clinical practice guidelines for kidney disease may be the ideal way forward. This was the...
A new ERA: The umbrella association seeking to speak with one...
Nicholas Inston (Queen Elizabeth Hospital Birmingham, Birmingham, UK), secretary of the Vascular Access Society (VAS) and chairman of the editorial board for Renal Interventions interviews Christoph...
Baxter reports Theranova dialyser may reduce cardiovascular events and hospitalisations
Baxter International, a global innovator in renal care, has announced new data showing expanded haemodialysis (HDx) therapy enabled by the company's Theranova dialyser may...
ERA-EDTA announces name change following late-breaking clinical data at 2021 congress
Fresh evidence on the usefulness of sonography to ease the burden of lung congestion in haemodialysis patients and “promising data” on a long-awaited targeted...